Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Search in:

Advanced search

Journal of Medical Economics Volume 23, 2020 - Issue 11

Submit an article Journal homepage

Open access

1,739

Views

CrossRef citations to date

Altmetric

Cardiovascular

Healthcare costs of NVAF patients treated with rivaroxaban and apixaban in the US

Dejan Milentijevica Real World Value & Evidence, Janssen Scientific Affairs, LLC, Titusville, NJ, USA

Guillaume Germainb Groupe d’analyse, Ltée, Montreal, CanadaCorrespondence[email protected]

François Lalibertéb Groupe d’analyse, Ltée, Montreal, Canada

Brahim K. Bookharta Real World Value & Evidence, Janssen Scientific Affairs, LLC, Titusville, NJ, USA

Sean D. MacKnightb Groupe d’analyse, Ltée, Montreal, Canada

Jenkin Tsangb Groupe d’analyse, Ltée, Montreal, Canada

Patrick Lefebvreb Groupe d’analyse, Ltée, Montreal, Canada

show all

Pages 1365-1374 | Received 07 Aug 2020, Accepted 03 Sep 2020, Published online: 29 Sep 2020

Cite this article
https://doi.org/10.1080/13696998.2020.1821038
CrossMark

Full Article
Figures & data
References
Supplemental
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF View EPUB EPUB

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (3)

Kueiyu Joshua Lin, Daniel E. Singer, Darae Ko, Robert Glynn, Mehdi Najafzadeh, Su Been Lee, Lily Gui Bessette, Alexander Cervone, Elyse DiCesare & Dae Hyun Kim. (2023) Frailty, Home Time, and Health Care Costs in Older Adults With Atrial Fibrillation Receiving Oral Anticoagulants. JAMA Network Open 6:11, pages e2342264.
Crossref

Manon Belhassen, Olivier Hanon, Philippe Gabriel Steg, Isabelle Mahé, Mélanie Née, Flore Jacoud, Faustine Dalon, François-Emery Cotté, Dominique Guitard-Dehoux, Claire Marant-Micallef, Eric Van Ganse & Nicolas Danchin. (2022) Apixaban versus other anticoagulants in patients with nonvalvular fibrillation: a comparison of all-cause and event-related costs in real-life setting in France. The European Journal of Health Economics 24:6, pages 867-875.
Crossref

Michael Situ, Ute I. Schwarz, Guangyong Zou, Eric McArthur, Richard B. Kim, Amit X. Garg & Sisira Sarma. (2023) Does prescribing apixaban or rivaroxaban versus warfarin for patients diagnosed with atrial fibrillation save health system costs? A multivalued treatment effects analysis. The European Journal of Health Economics.
Crossref

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references